Nov 11 (Reuters)-
Fuji Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Sep 30, 2016 Sep 30, 2015 Sep 30, 2017 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 34.23 31.68 36.30 17.47
(+8.0 pct) (+8.4 pct) (+6.0 pct) (+3.8 pct)
Operating 3.57 3.25 4.30 2.06
(+9.7 pct) (+2.5 pct) (+20.5 pct) (+13.2 pct)
Recurring 3.25 3.10 4.18 1.96
(+4.9 pct) (-3.1 pct) (+28.5 pct) (+13.6 pct)
Net
Net 2.12 2.09 2.80 1.31
(+1.2 pct) (+0.6 pct) (+32.2 pct) (+22.1 pct)
EPS 141.64 yen 137.55 yen 187.18 yen 87.57 yen
Ann Div 45.00 yen 44.00 yen 48.00 yen
-Q2 Div 21.00 yen 20.00 yen 23.00 yen
-Q4 Div 24.00 yen 24.00 yen 25.00 yen
NOTE - Fuji Pharmaceutical Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T
((Tokyo Headline News Desk +813 6441 1812))